Conflict of interest statement: Competing interests: None declared.49. Cancer Discov. 2018 May;8(5):OF5. doi: 10.1158/2159-8290.CD-NB2018-031. Epub 2018Mar 14.Direct-to-Consumer Test for BRCA Mutations Authorized.[No authors listed]The FDA authorized 23andMe to market the first direct-to-consumer test to checkfor three BRCA1/2 mutations associated with a higher risk of developing breast,ovarian, and prostate cancers. The mutations are most commonly found in about 2% of women of Ashkenazi Jewish descent.Â©2018 American Association for Cancer Research.DOI: 10.1158/2159-8290.CD-NB2018-031 PMID: 29540360 